Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1312815-35-2

Post Buying Request

1312815-35-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1312815-35-2 Usage

General Description

2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid is a chemical compound with a complex structure that contains a thiazole ring and a carboxylic acid group. It is a derivative of thiamine (vitamin B1) and is often used in the synthesis of thiamine analogs and related compounds. 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid has potential applications in the pharmaceutical industry, particularly in the development of drugs for the treatment of thiamine deficiency and related conditions. Its unique structure and functional groups make it a valuable building block for the synthesis of various bioactive molecules and pharmaceuticals. Additionally, it has been studied for its potential antioxidant and antimicrobial properties, making it of interest for a wide range of applications in medicine and biotechnology.

Check Digit Verification of cas no

The CAS Registry Mumber 1312815-35-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,8,1 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1312815-35:
(9*1)+(8*3)+(7*1)+(6*2)+(5*8)+(4*1)+(3*5)+(2*3)+(1*5)=122
122 % 10 = 2
So 1312815-35-2 is a valid CAS Registry Number.

1312815-35-2Relevant articles and documents

PROCESSES FOR THE PREPARATION OF FEBUXOSTAT AND SALTS THEREOF

-

Page/Page column 29, (2011/07/07)

There is provided a process for preparing febuxostat of formula (I) or a pharmaceutically acceptable salt thereof, the process comprising: condensing a compound of formula (A) with a compound of formula (B) to form an ester of febuxostat; hydrolyzing the ester of febuxostat to febuxostat, and optionally converting the febuxostat to a pharmaceutically acceptable salt thereof, wherein: R' is an activating group selected from boronic acid or lithium; R is selected from optionally substituted C1-4 alkyl or optionally substituted aryl; L is a leaving group selected from diazo, halo, -OSO2R", -OCOR" or -O-Si(R")3; and R" is selected from optionally substituted C1-4 alkyl or optionally substituted aryl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1312815-35-2